Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 38)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A ISIS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ISIS PHARMACEUTICALS INC 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ISIS PHARMACEUT -- ISIS 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: IDIX , ITMN , ISIS , MYGN , ORXE , OSIP -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ISIS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
16-Nov-09 PriceTarget Research, Inc. N/A ISIS Pharmaceuticals has a current Overall Rating of F (Lowest Rating). 7 $25 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ISIS PHARMACEUTICALS INC 5 $25 View Abstract
Next 20

Brokerage Reports (Showing 1 to 9 of 9)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
7-Nov-09 Thomson StreetEvents N/A ISIS - Event Brief of Isis Pharmaceuticals conference call, Nov. 05, 2009 / 8:30am ET 17 $75 View Abstract
7-Nov-09 Thomson StreetEvents N/A ISIS - Event Transcript of Isis Pharmaceuticals conference call, Nov. 05, 2009 / 8:30am ET 17 $75 View Abstract
5-Nov-09 Collins Stewart LLC Salveen J. Kochnover CFA 3Q09 EPS; Focus on Mipomersen Phase 3 HoFH data at AHA 8 $25 View Abstract
22-Oct-09 Thomson StreetEvents N/A ISIS - Event Transcript of Isis Pharmaceuticals conference call, Oct. 21, 2009 / 1:30pm ET 17 $75 View Abstract
22-Oct-09 Thomson StreetEvents N/A ISIS - Event Brief of Isis Pharmaceuticals conference call, Oct. 21, 2009 / 1:30pm ET 7 $75 View Abstract
22-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA Positive P2 ISIS-113715 Data is an Unexpected Surprise 6 $25 View Abstract
8-Oct-09 Thomson StreetEvents N/A ISIS - Event Transcript of Isis Pharmaceuticals conference call, Oct. 06, 2009 / 12:30pm ET 9 $75 View Abstract
20-Mar-09 Collins Stewart LLC Salveen J. Kochnover CFA Positive Physician Feedback on Mipomersen; Increasing PT to $20 11 $30 View Abstract
16-Mar-09 Thomson StreetEvents N/A ISIS.L - Event Transcript of F&C Asset Management plc conference call, Mar. 10, 2009 / 9:00am ET 17 $46.80 View Abstract

Independent Reports (Showing 1 to 10 of 29)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A ISIS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ISIS PHARMACEUTICALS INC 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ISIS PHARMACEUT -- ISIS 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: IDIX , ITMN , ISIS , MYGN , ORXE , OSIP -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ISIS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
16-Nov-09 PriceTarget Research, Inc. N/A ISIS Pharmaceuticals has a current Overall Rating of F (Lowest Rating). 7 $25 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ISIS PHARMACEUTICALS INC 5 $25 View Abstract
Next 19

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.